PeptideWise

How to Read a Peptide Certificate of Analysis (COA)

PeptideWise Editorial Team

A Certificate of Analysis is the single most important document for evaluating peptide quality, yet most people never learn how to read one. This guide breaks down every section of a real COA and explains what the numbers actually mean.

If you have ever looked at a peptide product and wondered whether the powder inside the vial actually matches the label, the answer lives in a document called the Certificate of Analysis, or COA. A COA is a formal report issued by a laboratory that details the identity, purity, and safety characteristics of a specific batch of product. It is the closest thing to a quality guarantee that exists in the peptide space, and understanding how to read one is an essential skill for anyone evaluating peptide products for research.

The problem is that most people glance at a COA, see a number like "98.5% purity," and stop there. A real COA contains far more information than a single purity figure, and each section tells you something important about whether the product is what it claims to be. This guide walks through every key component of a peptide COA, explains what the numbers mean, and shows you how to distinguish a legitimate batch-specific COA from a templated document that may not represent your actual product.

What a COA Is (and What It Is Not)

A Certificate of Analysis is a document produced after laboratory testing of a specific batch of a chemical compound. For peptides, this typically includes identity confirmation, purity measurement, and safety-related tests. The COA should be tied to a specific production batch, meaning the results apply only to the particular lot of peptide that was tested.

A COA is not a guarantee of efficacy. It tells you what is in the vial and how pure it is, but it does not tell you anything about whether the peptide will produce a specific biological effect. It is also not a substitute for regulatory approval. A peptide can have a perfect COA and still not be approved for human use. Think of the COA as a quality-control document, not a clinical endorsement.

HPLC Purity: The Number Everyone Looks At

High-Performance Liquid Chromatography (HPLC) is the standard method for measuring peptide purity. The technique works by dissolving the peptide sample in a solvent and passing it through a column packed with specialized material. Different molecules move through the column at different speeds based on their chemical properties, producing a chromatogram — a graph with peaks that represent each component in the sample.

The main peak represents the target peptide. Smaller peaks represent impurities — these might be truncated peptide sequences (where the synthesis stopped early), deletion sequences (where an amino acid was skipped), oxidized forms of the peptide, or residual reagents from manufacturing.

What the Purity Percentage Means

HPLC purity is expressed as a percentage of the total peak area. If the report states 98.5% purity, that means the target peptide accounts for 98.5% of all detectable material, and the remaining 1.5% consists of various impurities.

For research-grade peptides, purity levels generally fall into these ranges:

  • Greater than 98% — High purity, suitable for most research applications. This is generally considered the standard for reputable suppliers.
  • 95-98% — Acceptable for many applications, though impurity profiles should be examined more closely.
  • Below 95% — Lower grade. May be acceptable for certain preliminary studies but raises questions about manufacturing quality control.
  • Below 90% — Concerning for most applications. Significant impurity content may interfere with experimental results.

What to Look For Beyond the Number

A good COA will include the actual HPLC chromatogram — the graph itself, not just the percentage. The chromatogram lets you see the distribution of impurities. A clean chromatogram has one dominant peak with a smooth baseline and very small secondary peaks. A problematic chromatogram might show multiple significant peaks, a noisy baseline, or broad peaks that suggest poor separation.

You should also check the method details. The COA should specify the column type, mobile phase composition, gradient conditions, and detection wavelength (typically 214-220 nm for peptides). These details confirm that the test was actually performed rather than fabricated. A COA that reports purity without any method information is a red flag.

Mass Spectrometry: Confirming Identity

While HPLC tells you how pure the sample is, mass spectrometry (MS) tells you what the sample actually is. Mass spectrometry measures the molecular weight of the peptide with high precision, confirming that the compound in the vial matches the expected molecular structure.

How It Works

The peptide is ionized and sent through an analyzer that separates ions based on their mass-to-charge ratio (m/z). The result is a mass spectrum — a graph showing peaks at specific m/z values. The dominant peak should correspond to the theoretical molecular weight of the target peptide.

Reading the Mass Spec Data

A COA should report both the expected (theoretical) molecular weight and the observed molecular weight. For a legitimate sample, the observed value should be within a narrow margin of the expected value. For most peptide MS methods, a difference of less than 0.1% between expected and observed mass is considered acceptable. For example, if the expected molecular weight of a peptide is 1419.53 Da, an observed mass of 1419.47-1419.59 Da would be within normal range.

Common MS techniques used for peptides include MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight) and ESI-MS (Electrospray Ionization Mass Spectrometry). Both are well-established and reliable. The COA should specify which method was used.

If a COA does not include mass spectrometry data, you cannot confirm that the peptide is actually what the label says. HPLC alone can tell you that something is pure, but not what that something is. Both tests together provide identity and purity — you need both.

Endotoxin Testing: Measuring Bacterial Contamination

Endotoxins are components of the outer cell wall of gram-negative bacteria. They are extremely potent triggers of immune response in mammals and can cause fever, inflammation, and in severe cases, septic shock. Even after bacteria are killed through sterilization, their endotoxin fragments can persist and remain biologically active.

For any peptide intended for injection (even in a research context), endotoxin testing is a critical safety measure. The standard test is the Limulus Amebocyte Lysate (LAL) assay, which uses a reagent derived from horseshoe crab blood cells that reacts with endotoxins to form a clot or produce a measurable color change.

Reading Endotoxin Results

Endotoxin levels are reported in Endotoxin Units per milligram (EU/mg) or Endotoxin Units per milliliter (EU/mL). The USP (United States Pharmacopeia) limit for injectable products is generally less than 5 EU/kg of body weight per dose. For peptide COAs, you will typically see results reported as:

  • Less than 0.5 EU/mg — Very low, well within safety limits for most applications.
  • Less than 1.0 EU/mg — Generally acceptable.
  • Greater than 5.0 EU/mg — Elevated. Should be investigated further before use.

A COA that omits endotoxin testing entirely is a significant concern for any injectable product. While not all peptide vendors include this test (particularly at lower price points), its absence should factor into your quality assessment.

Residual Solvents: What Manufacturing Leaves Behind

Peptide synthesis involves multiple chemical reagents and solvents. After purification, trace amounts of these solvents may remain in the final product. The International Council for Harmonisation (ICH) classifies residual solvents into three categories based on their risk to human health:

  • Class 1 — Solvents that should be avoided (known or suspected carcinogens or environmental hazards). Examples include benzene and carbon tetrachloride.
  • Class 2 — Solvents with limited daily exposure. These are commonly used in peptide synthesis and include acetonitrile, dichloromethane, and dimethylformamide (DMF). Permitted daily exposure limits are defined by ICH Q3C guidelines.
  • Class 3 — Solvents with low toxicity. These include ethanol, acetone, and ethyl acetate. They have higher permitted limits.

What to Check

The COA should report residual solvent levels by name and quantity, measured in parts per million (ppm). The two solvents most commonly flagged in peptide COAs are acetonitrile (used in HPLC purification, Class 2, limit 410 ppm) and TFA (trifluoroacetic acid) (used as a counter-ion in synthesis, typically reported as TFA content percentage).

If residual solvent testing is absent from a COA, it does not necessarily mean the product is unsafe, but it does mean one layer of quality assurance was skipped. Reputable manufacturers and third-party labs routinely include this data.

Amino Acid Composition and Sequence Verification

Some more comprehensive COAs include amino acid analysis (AAA), which breaks the peptide down into its constituent amino acids and measures the ratio of each. This provides an additional layer of identity confirmation beyond mass spectrometry. If a peptide is supposed to contain specific amino acids in specific ratios, AAA confirms that the composition matches expectations.

Sequence analysis (such as Edman degradation or tandem MS/MS) goes even further by determining the order of amino acids, not just their presence. This level of testing is more common in pharmaceutical-grade analysis and is less frequently seen on standard research-grade COAs, though its presence is a strong indicator of thorough quality control.

How to Spot a Fake or Templated COA

Unfortunately, not every COA represents real testing of your specific product batch. Some documents are generic templates that may not correspond to the actual batch shipped to you. Here are the indicators that distinguish a real, batch-specific COA from a potentially fabricated one:

Signs of a Legitimate COA

  • Batch or lot number — Every legitimate COA should reference a specific batch number that matches the label on your product vial. If the batch number is missing, or if the same COA is provided for multiple orders placed months apart, that is a problem.
  • Date of analysis — The testing date should be recent relative to the manufacturing or shipping date. A COA dated two years before your order is suspect.
  • Laboratory name and contact information — A real COA identifies the testing laboratory with a name, address, and ideally an accreditation number. You should be able to verify that the laboratory exists and is accredited.
  • Analyst signature or identifier — Many labs include the name or initials of the analyst who performed the testing and a signature or electronic authentication.
  • Raw data or chromatograms — The inclusion of actual chromatograms, mass spectra, or other raw data is a strong sign of legitimacy. It is much harder to fabricate raw analytical data than to type numbers into a template.
  • Specific method references — Column specifications, gradient details, detection parameters, and instrument identifiers point to a real analysis.

Signs of a Templated or Suspicious COA

  • No batch number — or a batch number that does not match your product label.
  • Round numbers for every result — Legitimate analytical results almost always produce non-round numbers (e.g., 98.47%, not exactly 99.00%). If every value on the COA is suspiciously clean, the data may have been fabricated.
  • Missing chromatograms or spectra — Results reported as text only, with no supporting analytical data.
  • No laboratory identification — If the COA does not name the laboratory or provide verifiable contact details, you have no way to confirm the testing was performed.
  • Identical COAs across batches — If you order the same peptide twice, months apart, and receive identical COAs with the same batch number, the document is not batch-specific.
  • Formatting inconsistencies — Different fonts, misaligned tables, or other layout issues that suggest cut-and-paste assembly from multiple sources.

Why Third-Party Testing Matters More Than In-House Claims

A vendor who manufactures a peptide and then tests it in their own laboratory has an inherent conflict of interest. This does not mean in-house testing is worthless, but it does mean the results carry less weight than results from an independent third-party laboratory.

Third-party labs operate independently from the manufacturer. They have no financial incentive to produce favorable results, and their reputation depends on accuracy. When evaluating COAs, look for whether the testing was performed by the vendor themselves or by a named, accredited third-party laboratory.

Accreditation is another important factor. Laboratories accredited under ISO 17025 (the international standard for testing and calibration laboratories) have undergone external audits of their methods, equipment, and quality management systems. GMP (Good Manufacturing Practice) certification for the manufacturing facility itself is an additional, separate layer of quality assurance.

If a vendor claims third-party testing but cannot provide the name of the laboratory or a verifiable COA from that lab, treat the claim with skepticism. Legitimate third-party testing produces documentation that can be independently verified.

Putting It All Together: A COA Reading Checklist

When you receive a COA for a peptide product, work through this checklist:

  • Is the batch number present and does it match your product?
  • Is the testing date recent and reasonable?
  • Is the testing laboratory identified and verifiable?
  • Is HPLC purity reported, and is the chromatogram included?
  • Is the purity above 95%, ideally above 98%?
  • Is mass spectrometry data included?
  • Does the observed molecular weight match the theoretical value?
  • Are endotoxin test results present for injectable products?
  • Are endotoxin levels below 1.0 EU/mg?
  • Are residual solvent levels reported and within ICH limits?
  • Does the document look professionally produced with consistent formatting?
  • Do the results contain realistic non-round numbers?

No single factor on this list is definitive on its own. A COA might be missing one minor element and still represent legitimate testing. But the more boxes you can check, the more confidence you can have in the document and, by extension, in the product it describes.

The Role of COAs in Informed Decision-Making

Reading a COA carefully is one part of a broader quality evaluation process. It should be combined with other factors, including vendor reputation, transparent business practices, customer feedback from independent sources, and consistency across multiple orders. A single good COA does not guarantee that every future batch will meet the same standard — ongoing quality verification matters.

For researchers working with peptides like BPC-157, TB-500, or ipamorelin, the COA is your primary objective evidence of product quality. Learning to read one properly is a skill that pays dividends with every order you evaluate.

This article is for informational and educational purposes only and does not constitute medical advice.